Millions were booted from Medicaid. The insurers that run it gained Medicaid revenue anyway.

Private Medicaid health plans lost millions of members in the past year as pandemic protections that prohibited states from dropping anyone from the government program expired.

FDA approves anti-inflammatory drug Lodoco to treat cardiovascular disease

The FDA greenlighted on Tuesday an anti-inflammatory drug designed to reduce the risks related to cardiovascular disease. Agepha Pharma, a Dubai-based pharma, secured the approval

June 21, 2023

Daiichi Sankyo secures FDA approval for Vanflyta as AML treatment – Pharmaceutical Technology

The FDA opposed Vanflyta’s approval in 2019, citing concerns that the benefits of the drug’s efficacy did not justify the associated safety risks for AML

August 9, 2023

Opinion | Putting an End to the ‘Doctor-Nurse Game’

Libster is a psychiatric mental health clinical nurse specialist. In 1967, Leonard Stein, MD, coined the term “doctor-nurse game,” which he described as clear agreement

October 9, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.